TrimonilR-200mg-PRTablet-SE-AJ-ING

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example Ingredient: TrimonilR-200mg-PRTablet-SE-AJ-ING

Generated Narrative: Ingredient TrimonilR-200mg-PRTablet-SE-AJ-ING

status: Active

for:

MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100000400-00012920,http://ema.europa.eu/fhir/eurdId#539; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Prolonged-release tablet; indication = Epilepsi. Generaliserade toniska-kloniska anfall (grand mal). Partiella anfall. Trigeminusneuralgi. Alkoholabstinens.; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = carbamazepine
ManufacturedItemDefinition: status = active; manufacturedDoseForm = Prolonged-release tablet; unitOfPresentation = tablet
AdministrableProductDefinition: status = active; administrableDoseForm = Prolonged-release tablet

role: Active

substance
Codes
- Concept
* Carbamazepine
strength
presentation: 200 milligram(s) (Details: Unit of Measurement EMA code100000110655 = 'milligram(s)')/1 tablet (Details: Unit of Presentation EMA code200000002152 = 'Tablet')
referenceStrength
Substances
- Concept
* Carbamazepine
strength: 200 milligram(s) (Details: Unit of Measurement EMA code100000110655 = 'milligram(s)')/1 tablet (Details: Unit of Presentation EMA code200000002152 = 'Tablet')